Kosten der RiCO-Sicherheitsstudie für COVID-19-Impfstoffe

This is a written parliamentary inquiry regarding the expenses associated with the RiCO safety study. The procedure seeks to clarify the financial costs and funding details involved in monitoring the safety and efficacy of COVID-19 vaccines. This affects government budget oversight and public health administration. It ensures transparency regarding how public funds are used for medical research and vaccine safety surveillance.